C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22 | -37.1% | 11,921 | -6.9% | 0.00% | – |
Q2 2023 | $35 | -60.2% | 12,810 | -54.3% | 0.00% | -100.0% |
Q1 2023 | $88 | -64.1% | 28,013 | -32.6% | 0.00% | -66.7% |
Q4 2022 | $245 | -99.9% | 41,545 | +5.3% | 0.00% | -25.0% |
Q3 2022 | $346,000 | +44.8% | 39,458 | +24.6% | 0.00% | +33.3% |
Q2 2022 | $239,000 | +3.9% | 31,673 | +343.0% | 0.00% | +200.0% |
Q4 2021 | $230,000 | -56.2% | 7,149 | -39.1% | 0.00% | -50.0% |
Q3 2021 | $525,000 | +224.1% | 11,741 | +173.7% | 0.00% | +100.0% |
Q2 2021 | $162,000 | +10.2% | 4,290 | +8.0% | 0.00% | 0.0% |
Q1 2021 | $147,000 | – | 3,972 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |